SecBot SecBot
144 ·Filed Nov 12, 2026

VRTX

VERTEX PHARMACEUTICALS INC / MA
NEUTRAL
Impact 2/10
Horizonimmediate Processed5d 4h ago SEC0001959173-26-007958
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine insider intent-to-sell notice. The officer's holdings and the sale size relative to market cap are small. Monitor for actual execution on Form 4, but no material market impact is expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$542.62
T+0 close · Nov 12, 2026 · via day close
Latest settled
−0.74%
T+1 · $538.60
Vs SPY
−0.38%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 12 $542.62entry
  2. T+1 · 4d ago −0.74%α −0.38% · $538.60
  3. T+2 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Charles F. Wagner Jr., an officer of Vertex Pharmaceuticals, filed a Form 144 notice of intent to sell 15,286 shares of common stock, with an estimated market value of approximately $8.37 million based on the filing. The shares were acquired through ESPP purchases and restricted stock vesting between 2023 and 2025. The sale is scheduled for November 12, 2026.

Key Facts

  • Charles F. Wagner Jr., an officer of Vertex Pharmaceuticals, filed a Form 144 on November 12, 2026.
  • The filing indicates intent to sell 15,286 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $8,374,740.82.
  • Shares were acquired through ESPP purchases and restricted stock vesting between November 2023 and May 2025.
  • The proposed sale date is November 12, 2026.
  • The sale represents approximately 0.006% of Vertex's $138.9B market cap.

Financial Impact

Proposed sale of 15,286 shares valued at approximately $8.37 million, representing a small fraction of the company's $138.9B market cap.

dilution

Risk Factors

  • Insider sale may signal personal liquidity needs rather than negative outlook, but the small size limits concern.
  • The sale is not yet executed; the insider may choose not to sell.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (39 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007958
Document: 0001959173-26-007958-index.html0001959173-26-007958
Document: 0001959173-26-007958.txt0001959173-26-007958

Track record

21 reports on VRTX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +10.87% at T+60 after the Feb 25, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $537.79 Now $531.45 −1.18% settles Nov 24
  2. Nov 16, 20261d ago 144 Neutral 2/10 Entry $543.10 Now $531.45 −2.15% settles Nov 23
  3. Nov 16, 20261d ago 144 Neutral 1/10 Entry $544.98 Now $531.45 −2.48% settles Nov 23
  4. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $542.00 Now $531.45 −1.95% settles Nov 23
  5. Nov 12, 20265d ago 144 Neutral 2/10 Viewing Entry $542.62 Now $531.45 −2.06% settles Nov 19
  6. Nov 6, 202611d ago 144 Neutral 2/10 Entry $547.09 to $538.60 Now $531.45 −2.86% ▼ −1.55% −4.15% vs SPY
  7. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $530.76 to $547.89 Now $531.45 +0.13% ▲ +3.23% +3.81% vs SPY
  8. Oct 22, 202626d ago 3 Neutral 2/10 Entry $523.93 to $558.88 Now $531.45 +1.44% ▲ +6.67% +7.23% vs SPY
  9. Oct 20, 202628d ago 8-K Neutral 2/10 Entry $524.52 to $521.03 Now $531.45 +1.32% ▼ −0.67% −0.22% vs SPY
  10. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $500.36 to $517.49 Now $531.45 +6.21% ▲ +3.42% +3.57% vs SPY
Showing 10 of 21

US Market Status

Market Open · Closes in 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026